FERMENTALG EO -04
Fermentalg SA provides biosolutions based on aquatic micro-organisms in Europe, North America, Asia, and internationally. It offers DHA ORIGINS, a plant-based DHA oil; KALVEA PLUS, a nutritious algal protein concentrate dedicated to aquafeed applications; Everzure, an extract of natural acid stable blue color; BLUE ORIGINS AOX, an antioxidant and anti-inflammatory activities; and biobased raw mat… Read more
FERMENTALG EO -04 (1F6) - Net Assets
Latest net assets as of : €- EUR
Based on the latest financial reports, FERMENTALG EO -04 (1F6) has net assets worth €- EUR as of .
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€-) and total liabilities (€-). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €- |
| % of Total Assets | 0% |
| Annual Growth Rate | N/A |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | N/A |
FERMENTALG EO -04 - Net Assets Trend (None–None)
This chart illustrates how FERMENTALG EO -04's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for FERMENTALG EO -04 (None–None)
The table below shows the annual net assets of FERMENTALG EO -04 from None to None.
| Year | Net Assets | Change |
|---|---|---|
| No yearly data available. | ||
Equity Component Analysis
This analysis shows how different components contribute to FERMENTALG EO -04's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- No equity composition insights available.
FERMENTALG EO -04 Competitors by Market Cap
The table below lists competitors of FERMENTALG EO -04 ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Van Dien Fused Magnesium Phosphate Fertilizer JSC
VN:VAF
|
$29.45 Million |
|
Mural Oncology plc
NASDAQ:MURA
|
$29.47 Million |
|
Shapir Engineering Industry
TA:SPEN
|
$29.48 Million |
|
ALM EQUITY AB
F:I53
|
$29.48 Million |
|
Rein Therapeutics Inc
NASDAQ:RNTX
|
$29.44 Million |
|
Capital Small Finance Bank Limited
NSE:CAPITALSFB
|
$29.44 Million |
|
09women Co. Ltd.
KQ:366030
|
$29.43 Million |
|
Joong Ang Enervis Co. Ltd
KQ:000440
|
$29.43 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in FERMENTALG EO -04's equity between the two most recent reporting periods.
Insufficient data available to analyze equity growth attribution.
Book Value vs Market Value Analysis
This analysis compares FERMENTALG EO -04's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Insufficient data available to analyze book value vs market value.
Capital Efficiency Dashboard
This dashboard shows how efficiently FERMENTALG EO -04 utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Insufficient data available to analyze capital efficiency metrics.
Industry Comparison
This section compares FERMENTALG EO -04's net assets metrics with peer companies in the Biotechnology industry.
Industry Context
- Industry: Biotechnology
- Average net assets among peers: $1,291,084,078
- Average return on equity (ROE) among peers: -24.49%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| FERMENTALG EO -04 (1F6) | €- | N/A | N/A | $29.45 Million |
| 09R (09R) | $-3.01 Million | 0.00% | 0.00x | $11.12 Million |
| IDORSIA AG (19T) | $-968.72 Million | 0.00% | 0.00x | $532.51 Million |
| 1S90 (1S90) | $-44.86 Million | 0.00% | 0.00x | $51.72 Million |
| Strategic Partners A/S (1TB0) | $14.24 Million | -182.90% | 0.36x | $1.31 Million |
| 25K0 (25K0) | $-16.66 Million | 0.00% | 0.00x | $102.39 Million |
| 2BO (2BO) | $-37.78 Million | 0.00% | 0.00x | $6.23 Million |
| Intervacc AB (publ) (2E9) | $237.93 Million | -43.23% | 0.09x | $3.46 Million |
| 2F5 (2F5) | $-4.57 Million | 0.00% | 0.00x | $2.14 Million |
| 2H0 (2H0) | $14.92 Million | -17.30% | 0.56x | $9.25 Million |
| GNI Group Ltd (3G6) | $13.72 Billion | -1.46% | 0.26x | $772.60 Million |